Journal of Clinical Oncology

PRESIDENTIAL ADDRESS

From Illumination to Innovation: Visualizing the Future—The 2015 Presidential Address

Peter Paul Yu

J Clin Oncol 34:2679-2683, 2016

EDITORIALS

Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening

Stacy Loeb

J Clin Oncol 34:2684-2686, 2016

The Sound of Silence: A Proxy for Platinum Toxicity

Jan Oldenburg, et al.

J Clin Oncol 34:2687-2689, 2016

ORIGINAL REPORTS

Rapid Communication

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Margaretha G.M. Roemer, et al.

J Clin Oncol 34:2690-2697, 2016

Hematologic Malignancy

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

Alexander M. Lesokhin, et al.

J Clin Oncol 34:2698-2704, 2016

Urologic Oncology

Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer

Mark A. Preston, et al.

J Clin Oncol 34:2705-2711, 2016

Treatment-Related Complications

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer

Robert D. Frisina, et al.

J Clin Oncol 34:2712-2720, 2016

Gastrointestinal Cancer

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial Elizabeth C. Smyth, et al. J Clin Oncol 34:2721-2727, 2016 OPEN ACCESS ARTICLE

Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial

Nick Pavlakis, et al.

J Clin Oncol 34:2728-2735, 2016

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers

Peter C. Enzinger, et al.

J Clin Oncol 34:2736-2742, 2016

Breast Cancer

Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer

Lee W. Jones, et al.

J Clin Oncol 34:2743-2749, 2016

Age- and Tumor Subtype–Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

Marjanka K. Schmidt, et al.

J Clin Oncol 34:2750-2760, 2016

Thoracic Oncology

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma

Andreas Rimner, et al.

J Clin Oncol 34:2761-2768, 2016

Palliative and Supportive Care

Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response

Barry J.A. Laird, et al.

J Clin Oncol 34:2769-2775, 2016

Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial

Lars Tramsen, et al.

J Clin Oncol 34:2776-2783, 2016

ASCO SPECIAL ARTICLE

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Davendra P.S. Sohal, et al.

J Clin Oncol 34:2784-2796, 2016

CORRESPONDENCE

Is Stereotactic Body Radiotherapy Better Than Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma?

Jen-Fu Yang, et al.

J Clin Oncol 34:2797, 2016

Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?

Berardino De Bari, et al.

J Clin Oncol 34:2798-2799, 2016

Reply to Yang et al and De Bari et al

Daniel R. Wahl, et al.

J Clin Oncol 34:2799, 2016

Not All Androgen Deprivation Therapies Are Created Equal: Leuprolide and the Decreased Risk of Developing Alzheimer's Disease

Richard L. Bowen, et al.

J Clin Oncol 34:2800, 2016

Androgen Deprivation Therapy and Alzheimer's Disease

Michael Froehner, et al.

J Clin Oncol 34:2801, 2016

Association of Androgen Deprivation Therapy With Alzheimer’s Disease: Unmeasured Confounders

Jeffrey J. Leow, et al.

J Clin Oncol 34:2801-2803, 2016

Androgen Deprivation Therapy and Risk of Alzheimer’s Disease: Importance of Holistic Geriatric Oncology Assessment

Claire Brady, et al.

J Clin Oncol 34:2803-2804, 2016

Reply to R.L. Bowen et al, M. Froehner et al, J.L. Leow et al, and C. Brady et al

Kevin T. Nead, et al.

J Clin Oncol 34:2804-2805, 2016

ERRATUM

ERRATUM

J Clin Oncol 34:2806, 2016

ONCOLOGY CAREER CENTER

Advertising

J Clin Oncol 34:A615-A628, 2016